Company intelligence / Profile preview

Vaccine Industrial Holding

Riyadh, Riyadh, Saudi Arabia

Ownership: Private
Development stage: Other

Overview

Vaccine Industrial Holding LLC is establishing the first major human vaccine manufacturing facility in Saudi Arabia, aiming to transform the country into a regional and global hub for biomanufacturing; clinical products have not yet launched and the company is in the initial facility-building and R&D phase[1][2][3].

Modalities: VaccineBiologic
Industry: Biotech

Drug pipeline

1 asset

DTaP-IPV-HepB-Hib Vaccine

Preclinical

Partnerships

Emergex Vaccines Holding LimitedKing Abdulaziz City for Science and Technology (KACST)Center for Vaccine Development at Baylor College of Medicine

Beyond the preview

Go deeper on Vaccine Industrial Holding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaccine Industrial Holding.

Explore the full profile